Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Antibiotics as biological response modifiers.

R E Ritts1

  • 1Mayo Medical School, Mayo Clinic and Foundation, Rochester, Minnesota 55905.

The Journal of Antimicrobial Chemotherapy
|November 1, 1990
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Re: Particle migration after transurethral injection of carbon coated beads for stress urinary incontinence.

The Journal of urology·2002
Same author

CA 19-9 in pancreatic cancer.

Surgical oncology clinics of North America·1998
Same author

Comparison of preoperative serum CA19-9 levels with results of diagnostic imaging modalities in patients undergoing laparotomy for suspected pancreatic or gallbladder disease.

Pancreas·1994
Same author

Diagnostic role of serum CA 19-9 for cholangiocarcinoma in patients with primary sclerosing cholangitis.

Mayo Clinic proceedings·1993
Same author

Evidence for the elevation of serum carcinoembryonic antigen and tumor-associated glycoprotein-72 levels in patients administered interferons.

Cancer research·1991
Same author

Temporary elevation of CA 125 after abdominal surgical treatment for benign disease and cancer.

Surgery, gynecology & obstetrics·1989
Same journal

Favipiravir tissue distribution and inhibitory quotients in preclinical models: towards a pipeline for evidence-based antiviral repurposing.

The Journal of antimicrobial chemotherapy·2026
Same journal

A review of the randomized clinical trial results from the Staphylococcus aureus network adaptive platform (SNAP) meticillin-susceptible (MSSA) and penicillin-susceptible (PSSA) domains and CloCeBa.

The Journal of antimicrobial chemotherapy·2026
Same journal

Incidence and factors associated with subtherapeutic cefazolin levels among patients with severe infections.

The Journal of antimicrobial chemotherapy·2026
Same journal

Emerging resistance in staphylococci following long-term dalbavancin treatment for prosthetic joint infections.

The Journal of antimicrobial chemotherapy·2026
Same journal

Microbiology testing around the time of antibiotic initiation among residents of long-term care facilities.

The Journal of antimicrobial chemotherapy·2026
Same journal

Insights into the mechanisms underlying cell wall-active agents and gentamicin bactericidal synergism against Enterococcus faecalis.

The Journal of antimicrobial chemotherapy·2026
See all related articles

Infections and antibiotics significantly modulate the immune system. Antibiotics can be developed to enhance immune responses like phagocytosis and reduce harmful inflammatory factors, aiding in treating complex infections.

Area of Science:

  • Immunology
  • Pharmacology
  • Microbiology

Background:

  • Infections profoundly alter immune homeostasis.
  • Antibiotics, while targeting pathogens, can also influence immune responses.
  • Biological response modifying (BRM) activity is observed in both infection and antibiotic treatment.

Purpose of the Study:

  • To review the immunomodulatory roles of infections and antibiotics.
  • To explore desirable immunomodulatory activities for antibiotics.
  • To present in-vitro data on a specific antibiotic's immunomodulatory potential.

Main Methods:

  • Literature review of infection and antibiotic immunomodulation.
  • Analysis of potential antibiotic mechanisms for immune enhancement.
  • In-vitro experiments with cefodizime and human monocytes.

Related Experiment Videos

Main Results:

  • Infections and antibiotics act as potent immunomodulators.
  • Desired antibiotic activities include enhancing phagocytosis and inactivating lipopolysaccharide (LPS).
  • Cefodizime demonstrated the ability to down-regulate tumor necrosis factor (TNF) and interleukin-1 (IL-1) release.

Conclusions:

  • Antibiotics can be designed for dual roles: antimicrobial and immunomodulatory.
  • Targeting immune pathways offers therapeutic potential beyond direct pathogen killing.
  • Further research into immunomodulating antibiotics is warranted for complex diseases.